William Wilcox

Contact Information:

Email: william.wilcox@emory.edu

View Emory directory entry



SOM: Hum Gen: Admin

School Of Medicine

Other Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site, iTunes lectures, etc.):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 15

  1. 1
  2. 2


Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapy

by David G Warnock; Christie P Thomas; Bojan Vujkovac; Ruth C Campbell; Joel Charrow; Dawn Laney; Leslie L Jackson; William Wilcox; Christoph Wanner



Analysis of STAT1 Activation by Six FGFR3 Mutants Associated with Skeletal Dysplasia Undermines Dominant Role of STAT1 in FGFR3 Signaling in Cartilage

by Pavel Krejci; Lisa Salazar; Tamara A. Kashiwada; Katarina Chlebova; Alena Salasova; Leslie Michels Thompson; Vitezslav Bryja; Alois Kozubik; William R. Wilcox



Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy

by Raphael Schiffmann; David G. Warnock; Maryam Banikazemi; Jan Bultas; Gabor E. Linthorst; Seymour Packman; Sven Asger Sorensen; William R. Wilcox; Robert J. Desnick



Fibroblast growth factor receptor 3 interacts with and activates TGFβ-activated kinase 1 tyrosine phosphorylation and NFκB signaling in multiple myeloma and bladder cancer.

by Lisa Salazar; Tamara Kashiwada; Pavel Krejci; April N. Meyer; Malcolm Casale; Matthew Hallowell; William R. Wilcox; Daniel J. Donoghue; Leslie Michels Thompson



Receptor Tyrosine Kinases Activate Canonical WNT/beta-Catenin Signaling via MAP Kinase/LRP6 Pathway and Direct beta-Catenin Phosphorylation

by Pavel Krejci; Anie Aklian; Marketa Kaucka; Eva Sevcikova; Jirina Prochazkova; Jan Kukla Masek; Pavol Mikolka; Tereza Pospisilova; Tereza Spoustova; MaryAnn Weis; William A. Paznekas; Joshua H. Wolf; J. Silvio Gutkind; William R. Wilcox; Alois Kozubik; Ethylin Wang Jabs; Vitezslav Bryja; Lisa Salazar; Iva Vesela; Lukas Balek



The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat

by Elfrida R. Benjamin; Maria Cecilia Della Valle; Xiaoyang Wu; Evan Katz; Farhana Pruthi; Sarah Bond; Benjamin Bronfin; Hadis Williams; Julie Yu; Daniel G. Bichet; Dominique P. Germain; Roberto Giugliani; Derralynn Hughes; Raphael Schiffmann; William R. Wilcox; Robert J. Desnick; John Kirk; Jay Barth; Carrolee Barlow; Kenneth J. Valenzano; Jeff Castelli; David J. Lockhart



A Novel ZRS Mutation Leads to Preaxial Polydactyly Type 2 in a Heterozygous Form and Werner Mesomelic Syndrome in a Homozygous Form

by Julia E. VanderMeer; Reymundo Lozano; Miao Sun; Yuan Xue; Donna Daentl; Ethylin Wang Jabs; William R. Wilcox; Nadav Ahituv



Exome Sequencing Identified a Splice Site Mutation in FHL1 that Causes Uruguay Syndrome, an X-Linked Disorder With Skeletal Muscle Hypertrophy and Premature Cardiac Death

by Yuan Xue; Benedikt Schoser; Aliz R. Rao; Roberto Quadrelli; Alicia Vaglio; Verena Rupp; Christine Beichler; Stanley F. Nelson; Gudrun Schapacher-Tilp; Christian Windpassinger; William Wilcox



Clinical and radiographic delineation of Bent Bone Dysplasia-FGFR2 type or Bent Bone Dysplasia with Distinctive Clavicles and Angel-shaped Phalanges

by Deborah Krakow; Daniel H. Cohn; William Wilcox; Grace J. Noh; Leslie J. Raffel; Anna Sarukhanov; Margarita H. Ivanova; Moise Danielpour; Dorothy K. Grange; Alison M. Elliott; Jonathan A. Bernstein; David L. Rimoin; Amy E. Merrill; Ralph S. Lachman



Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease

by Dominique P. Germain; Joel Charrow; Robert J. Desnick; Nathalie Guffon; Judy Kempf; Robin H. Lachmann; Roberta Lemay; Gabor E. Linthorst; Seymour Packman; C. Ronald Scott; Stephen Waldek; David G. Warnock; Neal J. Weinreb; William Wilcox